FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Vioxx | Merck

SPOTLIGHT: Merck posts $1.6 billion loss

Tools

Merck reported a whopping $1.6 billion loss for the fourth quarter, mostly because of massive accounting charges related to its $4.85 billion Vioxx settlement. During the same period last year, Merck posted a $473.9 million profit. Meanwhile, some Florida patients left out of the Vioxx deal now want in. Report | Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:

More stories about Vioxx   Merck